765 related articles for article (PubMed ID: 25212219)
1. Botulinum toxin injection for hypercontractile or spastic esophageal motility disorders: may high-resolution manometry help to select cases?
Marjoux S; Brochard C; Roman S; Gincul R; Pagenault M; Ponchon T; Ropert A; Mion F
Dis Esophagus; 2015; 28(8):735-41. PubMed ID: 25212219
[TBL] [Abstract][Full Text] [Related]
2. Botulinum toxin reduces Dysphagia in patients with nonachalasia primary esophageal motility disorders.
Vanuytsel T; Bisschops R; Farré R; Pauwels A; Holvoet L; Arts J; Caenepeel P; De Wulf D; Mimidis K; Rommel N; Tack J
Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1115-1121.e2. PubMed ID: 23591282
[TBL] [Abstract][Full Text] [Related]
3. Current Therapeutic Options for Esophageal Motor Disorders as Defined by the Chicago Classification.
Zerbib F; Roman S
J Clin Gastroenterol; 2015 Jul; 49(6):451-60. PubMed ID: 25844840
[TBL] [Abstract][Full Text] [Related]
4. Complications of botulinum toxin injections for treatment of esophageal motility disorders†.
van Hoeij FB; Tack JF; Pandolfino JE; Sternbach JM; Roman S; Smout AJ; Bredenoord AJ
Dis Esophagus; 2017 Feb; 30(3):1-5. PubMed ID: 27337985
[TBL] [Abstract][Full Text] [Related]
5. Treatment of symptomatic nonachalasia esophageal motor disorders with botulinum toxin injection at the lower esophageal sphincter.
Miller LS; Parkman HP; Schiano TD; Cassidy MJ; Ter RB; Dabezies MA; Cohen S; Fisher RS
Dig Dis Sci; 1996 Oct; 41(10):2025-31. PubMed ID: 8888717
[TBL] [Abstract][Full Text] [Related]
6. The clinical significance of hypercontractile peristalsis: comparison of high-resolution manometric features, demographics, symptom presentation, and response to therapy in patients with Jackhammer esophagus versus Nutcracker esophagus.
Al-Qaisi MT; Siddiki HA; Crowell MD; Burdick GE; Fleischer DE; Ramirez FC; Vela MF
Dis Esophagus; 2017 Dec; 30(12):1-7. PubMed ID: 28881883
[TBL] [Abstract][Full Text] [Related]
7. Jackhammer esophagus with and without esophagogastric junction outflow obstruction demonstrates altered neural control resembling type 3 achalasia.
Quader F; Mauro A; Savarino E; Tolone S; de Bortoli N; Franchina M; Ghisa M; Edelman K; Jha LK; Penagini R; Gyawali CP
Neurogastroenterol Motil; 2019 Sep; 31(9):e13678. PubMed ID: 31310444
[TBL] [Abstract][Full Text] [Related]
8. Peroral endoscopic myotomy (POEM) is effective in treatment of noncardiac chest pain caused by hypercontractile esophageal motility disorders: results of the POEM-HYPE-Study.
Albers D; Frieling T; Dakkak D; Kuhlbusch-Zicklam R; Töx U; Gittinger M; Schumacher B
Z Gastroenterol; 2018 Nov; 56(11):1337-1342. PubMed ID: 30296811
[TBL] [Abstract][Full Text] [Related]
9. Botulinum toxin for the treatment of hypercontractile esophagus: Results of a double-blind randomized sham-controlled study.
Mion F; Marjoux S; Subtil F; Pioche M; Rivory J; Roman S; Zerbib F
Neurogastroenterol Motil; 2019 May; 31(5):e13587. PubMed ID: 30974039
[TBL] [Abstract][Full Text] [Related]
10. The Chicago classification of motility disorders: an update.
Roman S; Gyawali CP; Xiao Y; Pandolfino JE; Kahrilas PJ
Gastrointest Endosc Clin N Am; 2014 Oct; 24(4):545-61. PubMed ID: 25216902
[TBL] [Abstract][Full Text] [Related]
11. Esophageal hypertensive peristaltic disorders.
Roman S; Tutuian R
Neurogastroenterol Motil; 2012 Mar; 24 Suppl 1():32-9. PubMed ID: 22248106
[TBL] [Abstract][Full Text] [Related]
12. Hypercontractile esophagus: Clinical context and motors findings in high resolution manometry.
Martín-Domínguez V; Pérez-Fernández MT; Marinero A; Jusué-Irurita V; Caldas M; Santander C
Rev Esp Enferm Dig; 2015 May; 107(5):274-9. PubMed ID: 25952802
[TBL] [Abstract][Full Text] [Related]
13. Esophageal pharmacology and treatment of primary motility disorders.
Storr M; Allescher HD
Dis Esophagus; 1999; 12(4):241-57. PubMed ID: 10770358
[TBL] [Abstract][Full Text] [Related]
14. Two Distinct Types of Hypercontractile Esophagus: Classic and Spastic Jackhammer.
Hong YS; Min YW; Rhee PL
Gut Liver; 2016 Sep; 10(5):859-63. PubMed ID: 27458179
[TBL] [Abstract][Full Text] [Related]
15. The Chicago Classification of esophageal motility disorders, v3.0.
Kahrilas PJ; Bredenoord AJ; Fox M; Gyawali CP; Roman S; Smout AJ; Pandolfino JE;
Neurogastroenterol Motil; 2015 Feb; 27(2):160-74. PubMed ID: 25469569
[TBL] [Abstract][Full Text] [Related]
16. Clinical characteristics associated with esophageal motility function.
Tanaka Y; Ihara E; Nakamura K; Muta K; Fukaura K; Mukai K; Bai X; Takayanagi R
J Gastroenterol Hepatol; 2016 Jun; 31(6):1133-40. PubMed ID: 26670865
[TBL] [Abstract][Full Text] [Related]
17. Characterization and follow-up of esophagogastric junction outflow obstruction detected by high resolution manometry.
Pérez-Fernández MT; Santander C; Marinero A; Burgos-Santamaría D; Chavarría-Herbozo C
Neurogastroenterol Motil; 2016 Jan; 28(1):116-26. PubMed ID: 26517978
[TBL] [Abstract][Full Text] [Related]
18. Esophageal motility disorders in terms of pressure topography: the Chicago Classification.
Kahrilas PJ; Ghosh SK; Pandolfino JE
J Clin Gastroenterol; 2008; 42(5):627-35. PubMed ID: 18364587
[TBL] [Abstract][Full Text] [Related]
19. In-office transnasal esophagoscope-guided botulinum toxin injection of the lower esophageal sphincter.
Rees CJ
Curr Opin Otolaryngol Head Neck Surg; 2007 Dec; 15(6):409-11. PubMed ID: 17986880
[TBL] [Abstract][Full Text] [Related]
20. Treatment of chest pain in patients with noncardiac, nonreflux, nonachalasia spastic esophageal motor disorders using botulinum toxin injection into the gastroesophageal junction.
Miller LS; Pullela SV; Parkman HP; Schiano TD; Cassidy MJ; Cohen S; Fisher RS
Am J Gastroenterol; 2002 Jul; 97(7):1640-6. PubMed ID: 12135012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
